SMAD3 and gastric cancer: AMPK can inhibit the phosphorylation and the nuclear translocation of Smad3 protein, thus inhibiting the transcriptional regulatory functions of TGF-β.366,367 Therefore, inhibiting the phosphorylation of Smad3 may serve as a new therapeutic target for GC.